| Dr Joseph M Padeni, AUD | |
|
1201 5th Ave N, Suite 304, St Petersburg, FL 33705-1400 | |
| (727) 820-7708 | |
| (727) 820-7768 |
| Full Name | Dr Joseph M Padeni |
|---|---|
| Gender | Male |
| Speciality | Qualified Audiologist |
| Experience | 21 Years |
| Location | 1201 5th Ave N, St Petersburg, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376737643 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | AY802 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baycare Medical Group, Inc. | 6406753623 | 959 |
News Archive
A new blood test revealed more of the gene mutations that sustain certain digestive-tract tumors than did a DNA analysis of a traditional tumor biopsy, Dana-Farber Cancer Institute investigators will report at a special symposium of the American Association for Cancer Research annual meeting in Washington, April 6-10.
"Conditions in Zambia's prisons are so overcrowded and medical care so inadequate that they are breeding grounds for disease and pose a serious threat to public health, says a new report by Human Rights Watch, produced in association with the AIDS and Rights Alliance for Southern Africa and the Prisons Care and Counselling Association," BMJ News reports.
Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has notified the company of the tentative scheduling of a Psychopharmacologic Drugs Advisory Committee meeting on September 16, 2010, for the review of the company's supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) for opioid dependence.
Evidence shows that people with existing heart problems or who are at risk of developing them, are ignoring medical advice and not taking enough exercise.
Drugs taken by kidney transplant recipients to prevent organ rejection carry similar risks of cancer, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results suggest that no single medication is to blame for the higher incidence of cancer seen among patients who have undergone transplantation.
› Verified 4 days ago
| Provider Name | Baycare Medical Group, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1043269871 PECOS PAC ID: 6406753623 Enrollment ID: O20031216000718 |
News Archive
A new blood test revealed more of the gene mutations that sustain certain digestive-tract tumors than did a DNA analysis of a traditional tumor biopsy, Dana-Farber Cancer Institute investigators will report at a special symposium of the American Association for Cancer Research annual meeting in Washington, April 6-10.
"Conditions in Zambia's prisons are so overcrowded and medical care so inadequate that they are breeding grounds for disease and pose a serious threat to public health, says a new report by Human Rights Watch, produced in association with the AIDS and Rights Alliance for Southern Africa and the Prisons Care and Counselling Association," BMJ News reports.
Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has notified the company of the tentative scheduling of a Psychopharmacologic Drugs Advisory Committee meeting on September 16, 2010, for the review of the company's supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) for opioid dependence.
Evidence shows that people with existing heart problems or who are at risk of developing them, are ignoring medical advice and not taking enough exercise.
Drugs taken by kidney transplant recipients to prevent organ rejection carry similar risks of cancer, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results suggest that no single medication is to blame for the higher incidence of cancer seen among patients who have undergone transplantation.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph M Padeni, AUD 1201 5th Ave N Ste 304, St Petersburg, FL 33705-1425 Ph: (727) 820-7708 | Dr Joseph M Padeni, AUD 1201 5th Ave N, Suite 304, St Petersburg, FL 33705-1400 Ph: (727) 820-7708 |
News Archive
A new blood test revealed more of the gene mutations that sustain certain digestive-tract tumors than did a DNA analysis of a traditional tumor biopsy, Dana-Farber Cancer Institute investigators will report at a special symposium of the American Association for Cancer Research annual meeting in Washington, April 6-10.
"Conditions in Zambia's prisons are so overcrowded and medical care so inadequate that they are breeding grounds for disease and pose a serious threat to public health, says a new report by Human Rights Watch, produced in association with the AIDS and Rights Alliance for Southern Africa and the Prisons Care and Counselling Association," BMJ News reports.
Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has notified the company of the tentative scheduling of a Psychopharmacologic Drugs Advisory Committee meeting on September 16, 2010, for the review of the company's supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) for opioid dependence.
Evidence shows that people with existing heart problems or who are at risk of developing them, are ignoring medical advice and not taking enough exercise.
Drugs taken by kidney transplant recipients to prevent organ rejection carry similar risks of cancer, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results suggest that no single medication is to blame for the higher incidence of cancer seen among patients who have undergone transplantation.
› Verified 4 days ago
Barry J. Robbins, M.S. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 601 7th St S, St Petersburg, FL 33701 Phone: 727-824-7170 Fax: 727-824-7142 | |
Mr. Daniel P Gardner, M.S., CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 970 Lake Carillon Dr, Ste 300, St Petersburg, FL 33716 Phone: 727-202-8924 Fax: 352-795-8663 | |
Christina Adams, MS CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 880 6th St S, Suite 170, St Petersburg, FL 33701 Phone: 727-767-8989 Fax: 727-767-8998 | |
Skye Dorsett Quamina, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 6827 1st Ave S Ste 100, St Petersburg, FL 33707 Phone: 727-341-0551 Fax: 727-341-0332 | |
Dr. Risa Beth Barnett-padeni, AUD. CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 880 6th St S Ste 170, St Petersburg, FL 33701 Phone: 727-767-8314 Fax: 727-767-8998 | |
Dr. Sybil Prewitt Faylo, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 880 6th St S, Suite 170, St Petersburg, FL 33701 Phone: 727-767-8989 Fax: 727-767-8998 | |
Vangie Neeley, AU. D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 801 6th St S, St Petersburg, FL 33701 Phone: 727-767-8989 |